{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:58Z","timestamp":1761630718783,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ad.2015.01.007","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T18:34:41Z","timestamp":1427308481000},"page":"376-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Estrategias terap\u00e9uticas innovadoras para la epiderm\u00f3lisis bullosa distr\u00f3fica recesiva"],"prefix":"10.1016","volume":"106","author":[{"given":"F.","family":"Larcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Del R\u00edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2015.01.007_bib0225","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-5-12","article-title":"Inherited epidermolysis bullosa","volume":"5","author":"Fine","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ad.2015.01.007_bib0230","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.12703\/P6-35","article-title":"Advances in understanding and treating dystrophic epidermolysis bullosa","volume":"6","author":"Vanden Oever","year":"2014","journal-title":"F1000 Prime Rep"},{"key":"10.1016\/j.ad.2015.01.007_bib0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2133.2010.09713.x","article-title":"The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation","volume":"163","author":"Esc\u00e1mez","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2350-11-139","article-title":"A prevalent mutation with founder effect in Spanish recessive dystrophic epidermolysis bullosa families","volume":"11","author":"Cuadrado-Corrales","year":"2010","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.ad.2015.01.007_bib0250","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/jid.2010.163","article-title":"Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa","volume":"130","author":"Pasmooij","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0255","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/jid.2013.10","article-title":"Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa","volume":"133","author":"Woodley","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0260","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2015.01.007_bib0265","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(13)61897-8","article-title":"Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: Repair of the extracellular matrix","volume":"382","author":"Tolar","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2015.01.007_bib0270","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","article-title":"PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia","volume":"108","author":"Tamai","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ad.2015.01.007_bib0275","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model for dystrophic epidermolysis bullosa reveals disease mechanisms and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ad.2015.01.007_bib0280","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysisbullosa: High stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0285","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0290","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","article-title":"Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosawounds: Results of a randomized, vehicle-controlled trial","volume":"169","author":"Petrof","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0295","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/jcb.20904","article-title":"Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue","volume":"99","author":"Izadpanah","year":"2006","journal-title":"J Cell Biochem"},{"issue":"1 Suppl","key":"10.1016\/j.ad.2015.01.007_bib0300","first-page":"S71","article-title":"Comparing mesenchymal stromal cells from different human tissues: Bone marrow, adipose tissue and umbilical cord blood","volume":"18","author":"Bieback","year":"2008","journal-title":"Biomed Mater Eng"},{"key":"10.1016\/j.ad.2015.01.007_bib0305","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/scrt2","article-title":"Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications","volume":"1","author":"Ghannam","year":"2010","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0310","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ad.2015.01.007_bib0315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4161\/org.27405","article-title":"Activity of mesenchymal stem cells in therapies for chronic skin wound healing","volume":"10","author":"Nuschke","year":"2014","journal-title":"Organogenesis"},{"key":"10.1016\/j.ad.2015.01.007_bib0320","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jaad.2003.08.013","article-title":"Clinical trial of allogeneic cultured dermal substitute for thetreatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa","volume":"50","author":"Hasegawa","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ad.2011.03.006","article-title":"Skin bioengineering: Preclinical and clinical applications","volume":"103","author":"Mart\u00ednez-Santamar\u00eda","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2015.01.007_bib0330","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1089\/hum.2004.15.921","article-title":"Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa","volume":"15","author":"Gache","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0335","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/mt.2008.204","article-title":"Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors","volume":"16","author":"Di Nunzio","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0340","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ad.2015.01.007_bib0345","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/hum.2010.023","article-title":"Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue","volume":"21","author":"Siprashvili","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0350","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/mt.2010.91","article-title":"SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa","volume":"18","author":"Titeux","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0355","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.gt.3301978","article-title":"Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer","volume":"10","author":"Ortiz-Urda","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0360","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-61779-767-5_15","article-title":"Antisense-mediated exon skipping to reframe transcripts","volume":"867","author":"Turczynski","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ad.2015.01.007_bib0365","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/jid.2010.249","article-title":"Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa","volume":"131","author":"Murauer","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0370","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/mt.2014.140","article-title":"Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: Therapeutic implications for dystrophic epidermolysis bullosa","volume":"22","author":"Cogan","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0375","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1371\/journal.pgen.0020133","article-title":"A look to future directions in gene therapy research for monogenic diseases","volume":"2","author":"Porteus","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ad.2015.01.007_bib0380","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.3721","article-title":"Genome editing. A tool for research and therapy:Targeted genome editing hits the clinic","volume":"20","author":"Lombardo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.ad.2015.01.007_bib0385","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","article-title":"TALEN-based gene correction for epidermolysis bullosa","volume":"21","author":"Osborn","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0390","first-page":"1","article-title":"Polyglutamine disease modeling: Epitope based screen for homologous recombination using CRISPR\/Cas9 System","volume":"6","author":"An","year":"2014","journal-title":"PLoS Curr"},{"key":"10.1016\/j.ad.2015.01.007_bib0395","doi-asserted-by":"crossref","DOI":"10.1007\/7651_2014_73","article-title":"Genetic modification in human pluripotent stem cells by homologous recombination and CRISPR\/Cas9 system","author":"Xue","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ad.2015.01.007_bib0400","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s13238-014-0032-5","article-title":"Homologous recombination in human embryonic stem cells using CRISPR\/Cas9 nickase and a long DNA donor template","volume":"5","author":"Rong","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.ad.2015.01.007_bib0405","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/mt.2013.111","article-title":"Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients","volume":"21","author":"Ousterout","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0410","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/sj.mt.6300238","article-title":"Long-term engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy","volume":"15","author":"Larcher","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.ad.2015.01.007_bib0415","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/jid.2013.308","article-title":"Long-term survival of type XVII collagen revertant cells in an animal model of revertant cell therapy","volume":"134","author":"Gosty\u0144ski","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0420","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaad.2013.08.052","article-title":"Successful therapeutic transplantation of revertant skin in epidermolysis bullosa","volume":"70","author":"Gosty\u0144ski","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2015.01.007_bib0425","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/embj.201387098","article-title":"iPS cells: A game changer for future medicine","volume":"33","author":"Inoue","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.ad.2015.01.007_bib0430","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(09)61496-3","article-title":"Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: A preclinical study","volume":"374","author":"Guenou","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2015.01.007_bib0435","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1073\/pnas.1100332108","article-title":"Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells","volume":"108","author":"Itoh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ad.2015.01.007_bib0440","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/jid.2013.523","article-title":"Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa","volume":"134","author":"Tolar","year":"2014","journal-title":"J Invest Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731015000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:03:56Z","timestamp":1757552636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731015000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0001731015000691"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2015.01.007","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrategias terap\u00e9uticas innovadoras para la epiderm\u00f3lisis bullosa distr\u00f3fica recesiva","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2015.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}